Evidence map›Paper›PMID 27351354›Full record

ReviewCurrent opinion in microbiology2016

Alarmin(g) the innate immune system to invasive fungal infections.

Alayna K Caffrey, Joshua J Obar

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mechanism of Candida pathogenesis: revisiting the vital drivers.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Review
  9. Review
  10. Danger signals in oral cavity-related diseases.Journal of leukocyte biology · 2019
    Review
  11. Review
  12. Article
  13. Review
  14. Prescribing Pattern of Antifungal Medications at a Tertiary Care Hospital in Oman.Journal of clinical and diagnostic research : JCDR · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alayna K CaffreyMontana State University, Department of Microbiology & Immunology, Bozeman, MT 59718, United States; Geisel School of Medicine at Dartmouth, Department of Microbiology & Immunology, Lebanon, NH 03756, United States.
Joshua J ObarGeisel School of Medicine at Dartmouth, Department of Microbiology & Immunology, Lebanon, NH 03756, United States. Electronic address: joshua.j.obar@dartmouth.edu.

Funding

TRANSLATIONAL RESEARCH COREP30GM106394 · NIGMS · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2013 to 2017
$6.1M
Center for Molecular, Cellular, and Translational ImmunologyP30GM103415 · NIGMS · DARTMOUTH COLLEGE · PI GREEN, WILLIAM R · 2012 to 2015
$4.7M
NIGMS NIH HHS P30 GM103415NIGMS NIH HHS P30 GM106394
6 · The paper itself

Abstract

Fungi encounter numerous stresses in a mammalian host, including the immune system, which they must adapt to in order to grow and cause disease. The host immune system tunes its response to the threat level posed by the invading pathogen. We discuss recent findings on how interleukin (IL)-1 signaling is central to tuning the immune response to the virulence potential of invasive fungi, as well as other pathogens. Moreover, we discuss fungal factors that may drive tissue invasion and destruction that regulate IL-1 cytokine release. Moving forward understanding the mechanisms of fungal adaption to the host, together with understanding how the host innate immune system recognizes invading fungal pathogens will increase our therapeutic options for treatment of invasive fungal infections.

Indexed as

AlarminsAnimalsAspergillosisAspergillusCandidaCandidiasisHost-Pathogen InteractionsImmunity, InnateInterleukin-1Invasive Fungal InfectionsSignal TransductionAlarminsInterleukin-1

Identifiers

PMID27351354
PMCPMC4983492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.